Avenue Therapeutics Inc (ATXI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATXI Annual Balance Sheets →
This balance sheet overview for Avenue Therapeutics Inc spans from Jun 30 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1.94
Cash & Short-term Investments1.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current0.03
Total Current Assets1.98
Total Assets1.98
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.00
Derivative Liability, Current DE0.00
Other Liabilities, Current1.41
Total Current Liabilities1.41
Total Long-term Debt0.00
Total Liabilities1.41
Stockholders' Equity
Additional Paid In Capital Common Stock107.44
Retained Earnings / Accumulated Deficit-106.87
Other Equity0.00
Common Stockholder's Equity0.57
Non-controlling interests & other0.00
Total Stockholder's Equity0.57
Liabilities & Stockholder's Equity1.98
4 historic quarters locked

Sign in to unlock the full Avenue Therapeutics Inc balance sheet history.

About Avenue Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-026372

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.